Basic Search
|
Summaries
|
Advanced Search
Violation Tracker UK Parent Industry Summary Page
Parent Industry: pharmaceuticals
Penalty Total since 2010: £232,897,375
Number of Cases: 28
Note: The totals include only those entries matched to a parent company. The industry designation is the primary one for the parent's operations overall.
| Top 10 Parent Companies | Penalty Total | Number of Cases |
| Intas Pharmaceuticals Ltd. | £134,425,098 | 3 |
| Pfizer | £63,300,000 | 1 |
| GlaxoSmithKline | £22,055,000 | 5 |
| Alliance Pharma PLC | £7,900,000 | 1 |
| Johnson & Johnson | £4,829,000 | 1 |
| Curia Inc. | £168,345 | 3 |
| Sandoz Group | £120,932 | 2 |
| Novo Holdings A/S | £60,000 | 1 |
| Gilead Sciences | £35,000 | 1 |
| Elanco Animal Health | £3,250 | 1 |
Individual Penalty Cases:
Click on the company or penalty amount for more information on each case. Click on the parent name to reach the summary page for that parent company.
Download results as
CSV
or
XML
(maximum 1000; for access to larger downloads contact
Phil Mattera)
| Company | Parent | Offence Type | Year | Agency  | Penalty Amount |
| Auden Mckenzie (Pharma Division) Ltd. and Accord-UK Ltd. | Intas Pharmaceuticals Ltd. | price-fixing or anti-competitive practices | 2020 | UK-CMA | £2,882,238 |
| GlaxoSmithKline plc and GlaxoSmithKline UK Ltd. and SmithKline Beecham Ltd. and Beecham Group plc | GlaxoSmithKline | price-fixing or anti-competitive practices | 2016 | UK-CMA | £22,000,000 |
| Actavis UK Ltd. | Intas Pharmaceuticals Ltd. | price-fixing or anti-competitive practices | 2016 | UK-CMA | £1,542,860 |
| Alliance Pharmaceuticals Limited and Alliance Pharma plc | Alliance Pharma PLC | price-fixing or anti-competitive practices | 2022 | UK-CMA | £7,900,000 |
| Pfizer Limited | Pfizer | price-fixing or anti-competitive practices | 2022 | UK-CMA | £63,300,000 |
| Auden Mckenzie and Actavis UK | Intas Pharmaceuticals Ltd. | price-fixing or anti-competitive practices | 2023 | UK-CMA | £130,000,000 |
| Sandoz Limited | Sandoz Group | environmental violation | 2014 | UK-EA | £0 |
| Sandoz Limited | Sandoz Group | environmental violation | 2017 | UK-EA | £120,932 |
| Novartis Animal Vaccines Limited | Elanco Animal Health | environmental violation | 2013 | UK-EA | £3,250 |
| Novo Nordisk Ltd | Novo Holdings A/S | environmental violation | 2012 | UK-EA | £60,000 |
| SmithKline Beecham Ltd | GlaxoSmithKline | environmental violation | 2012 | UK-EA | £0 |
| Gilead Sciences Ltd | Gilead Sciences | labour standards violation | 2023 | UK-ET | £35,000 |
| SmithKline Beecham Limited | GlaxoSmithKline | workplace safety or health violation | 2021 | UK-HSE | £0 |
| Boehringer-Ingelheim Animal Health UK Ltd | Boehringer Ingelheim | workplace safety or health violation | 2020 | UK-HSE | £0 |
| Novartis Grimsby Limited | Novartis | workplace safety or health violation | 2018 | UK-HSE | £0 |
| Novartis Grimsby Limited | Novartis | workplace safety or health violation | 2018 | UK-HSE | £0 |
| Novartis Grimsby Limited | Novartis | workplace safety or health violation | 2017 | UK-HSE | £0 |
| GlaxoSmithKline Research & Development Limited | GlaxoSmithKline | workplace safety or health violation | 2017 | UK-HSE | £0 |
| Indivior UK Limited | Indivior PLC | workplace safety or health violation | 2016 | UK-HSE | £0 |
| Indivior UK Limited | Indivior PLC | workplace safety or health violation | 2016 | UK-HSE | £0 |
| GlaxoSmithKline PLC | GlaxoSmithKline | workplace safety or health violation | 2013 | UK-HSE | £55,000 |
| Euticals Limited | Curia Inc. | workplace safety or health violation | 2012 | UK-HSE | £20,000 |
| Euticals Limited | Curia Inc. | workplace safety or health violation | 2011 | UK-HSE | £108,345 |
| AstraZeneca UK Limited | AstraZeneca | workplace safety or health violation | 2022 | UK-HSE | £0 |
| Euticals Ltd | Curia Inc. | Environmental Violation | 2013 | UK-NRW | £40,000 |
| DePuy International Limited | Johnson & Johnson | bribery | 2011 | UK-SFO | £4,829,000 |
| AstraZeneca UK Ltd | AstraZeneca | pension plan violation | 2014 | UK-TPO | £250 |
| Schering-Plough Senior Management Pension Plan | Merck | pension plan violation | 2017 | UK-TPR | £500 |
